These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 18423312

  • 1. Pharmacokinetic analysis of malignant pleural mesothelioma-initial results of tumor microcirculation and its correlation to microvessel density (CD-34).
    Giesel FL, Choyke PL, Mehndiratta A, Zechmann CM, von Tengg-Kobligk H, Kayser K, Bischoff H, Hintze C, Delorme S, Weber MA, Essig M, Kauczor HU, Knopp MV.
    Acad Radiol; 2008 May; 15(5):563-70. PubMed ID: 18423312
    [Abstract] [Full Text] [Related]

  • 2. Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a feasibility study of noninvasive assessment, therapeutic follow-up, and possible predictor of improved outcome.
    Giesel FL, Bischoff H, von Tengg-Kobligk H, Weber MA, Zechmann CM, Kauczor HU, Knopp MV.
    Chest; 2006 Jun; 129(6):1570-6. PubMed ID: 16778277
    [Abstract] [Full Text] [Related]

  • 3. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
    Lowry M, Zelhof B, Liney GP, Gibbs P, Pickles MD, Turnbull LW.
    Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 3D dynamic contrast-enhanced MRI of rectal carcinoma at 3T: correlation with microvascular density and vascular endothelial growth factor markers of tumor angiogenesis.
    Zhang XM, Yu D, Zhang HL, Dai Y, Bi D, Liu Z, Prince MR, Li C.
    J Magn Reson Imaging; 2008 Jun; 27(6):1309-16. PubMed ID: 18504761
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.
    Oto A, Fan X, Mustafi D, Jansen SA, Karczmar GS, Rubin DT, Kayhan A.
    Acad Radiol; 2009 Oct; 16(10):1223-30. PubMed ID: 19524458
    [Abstract] [Full Text] [Related]

  • 9. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer.
    Su MY, Cheung YC, Fruehauf JP, Yu H, Nalcioglu O, Mechetner E, Kyshtoobayeva A, Chen SC, Hsueh S, McLaren CE, Wan YL.
    J Magn Reson Imaging; 2003 Oct; 18(4):467-77. PubMed ID: 14508784
    [Abstract] [Full Text] [Related]

  • 10. Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas.
    Toms AP, White LM, Kandel R, Bleakney RR, Noseworthy M, Lee S, Blackstein ME, Wunder J.
    Acta Radiol; 2009 Jun; 50(5):512-20. PubMed ID: 19431058
    [Abstract] [Full Text] [Related]

  • 11. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement.
    Hawighorst H, Knapstein PG, Weikel W, Knopp MV, Zuna I, Knof A, Brix G, Schaeffer U, Wilkens C, Schoenberg SO, Essig M, Vaupel P, van Kaick G.
    Cancer Res; 1997 Nov 01; 57(21):4777-86. PubMed ID: 9354439
    [Abstract] [Full Text] [Related]

  • 12. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA, Cutajar M, Gordon I.
    Eur J Radiol; 2009 Sep 01; 71(3):576-81. PubMed ID: 19004588
    [Abstract] [Full Text] [Related]

  • 13. Method for quantitation of dynamic MRI contrast agent uptake in colorectal liver metastases.
    van Laarhoven HW, Rijpkema M, Punt CJ, Ruers TJ, Hendriks JC, Barentsz JO, Heerschap A.
    J Magn Reson Imaging; 2003 Sep 01; 18(3):315-20. PubMed ID: 12938126
    [Abstract] [Full Text] [Related]

  • 14. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
    Aref M, Chaudhari AR, Bailey KL, Aref S, Wiener EC.
    Magn Reson Imaging; 2008 Nov 01; 26(9):1279-93. PubMed ID: 18487033
    [Abstract] [Full Text] [Related]

  • 15. Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer.
    de Lussanet QG, Backes WH, Griffioen AW, Padhani AR, Baeten CI, van Baardwijk A, Lambin P, Beets GL, van Engelshoven JM, Beets-Tan RG.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1309-15. PubMed ID: 16125874
    [Abstract] [Full Text] [Related]

  • 16. Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI.
    Su MY, Baik HM, Yu HJ, Chen JH, Mehta RS, Nalcioglu O.
    Technol Cancer Res Treat; 2006 Aug 01; 5(4):401-10. PubMed ID: 16866570
    [Abstract] [Full Text] [Related]

  • 17. Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling.
    Benjaminsen IC, Brurberg KG, Ruud EB, Rofstad EK.
    Magn Reson Imaging; 2008 Feb 01; 26(2):160-70. PubMed ID: 17692490
    [Abstract] [Full Text] [Related]

  • 18. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.
    Zahra MA, Tan LT, Priest AN, Graves MJ, Arends M, Crawford RA, Brenton JD, Lomas DJ, Sala E.
    Int J Radiat Oncol Biol Phys; 2009 Jul 01; 74(3):766-73. PubMed ID: 19019563
    [Abstract] [Full Text] [Related]

  • 19. Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma.
    Hillengass J, Wasser K, Delorme S, Kiessling F, Zechmann C, Benner A, Kauczor HU, Ho AD, Goldschmidt H, Moehler TM.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 1):475-81. PubMed ID: 17255268
    [Abstract] [Full Text] [Related]

  • 20. Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium-DTPA-enhanced MRI and localized 19F MRS pharmacokinetic studies of 5-fluorouracil.
    van Laarhoven HW, Klomp DW, Rijpkema M, Kamm YL, Wagener DJ, Barentsz JO, Punt CJ, Heerschap A.
    NMR Biomed; 2007 Apr 15; 20(2):128-40. PubMed ID: 17006886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.